2017 Q2 Form 10-Q Financial Statement

#000143774917014436 Filed on August 10, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.570M $4.290M
YoY Change -16.78% 34.48%
% of Gross Profit
Research & Development $4.650M $4.988M
YoY Change -6.78% 80.2%
% of Gross Profit
Depreciation & Amortization $80.00K $30.00K
YoY Change 166.67% 50.0%
% of Gross Profit
Operating Expenses $8.224M $9.275M
YoY Change -11.33% 55.73%
Operating Profit -$8.224M -$9.275M
YoY Change -11.33% 55.73%
Interest Expense $1.443M $1.475M
YoY Change -2.17% 125.54%
% of Operating Profit
Other Income/Expense, Net $1.703M $19.04M
YoY Change -91.06% -180.04%
Pretax Income -$6.521M $9.764M
YoY Change -166.79% -132.83%
Income Tax -$4.000K -$4.000K
% Of Pretax Income -0.04%
Net Earnings -$6.517M $9.768M
YoY Change -166.72% -132.84%
Net Earnings / Revenue
Basic Earnings Per Share -$0.44 $0.59
Diluted Earnings Per Share -$0.44 -$0.58
COMMON SHARES
Basic Shares Outstanding 14.65M 14.60M
Diluted Shares Outstanding 14.65M 15.44M

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $53.50M $82.60M
YoY Change -35.23% 28.66%
Cash & Equivalents $12.39M $27.51M
Short-Term Investments $41.10M $55.10M
Other Short-Term Assets $1.900M $1.900M
YoY Change 0.0% 216.67%
Inventory
Prepaid Expenses
Receivables
Other Receivables $0.00
Total Short-Term Assets $55.36M $84.57M
YoY Change -34.53% 30.45%
LONG-TERM ASSETS
Property, Plant & Equipment $2.148M $1.105M
YoY Change 94.39% 213.92%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $11.20M $18.90M
YoY Change -40.74%
Other Assets $321.0K $111.0K
YoY Change 189.19% 98.21%
Total Long-Term Assets $13.68M $20.07M
YoY Change -31.81% 1074.14%
TOTAL ASSETS
Total Short-Term Assets $55.36M $84.57M
Total Long-Term Assets $13.68M $20.07M
Total Assets $69.05M $104.6M
YoY Change -34.01% 57.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.300M $5.400M
YoY Change 16.67% 10.2%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $200.0K $2.000M
YoY Change -90.0%
Total Short-Term Liabilities $6.592M $7.391M
YoY Change -10.81% 50.53%
LONG-TERM LIABILITIES
Long-Term Debt $92.00M $90.40M
YoY Change 1.77% 378.31%
Other Long-Term Liabilities $1.472M $478.0K
YoY Change 207.95% -98.78%
Total Long-Term Liabilities $1.472M $478.0K
YoY Change 207.95% -99.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.592M $7.391M
Total Long-Term Liabilities $1.472M $478.0K
Total Liabilities $108.3M $104.3M
YoY Change 3.86% 65.36%
SHAREHOLDERS EQUITY
Retained Earnings -$144.2M -$97.99M
YoY Change 47.14% 14.11%
Common Stock $104.9M $98.32M
YoY Change 6.69% 10.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$39.28M $333.0K
YoY Change
Total Liabilities & Shareholders Equity $69.05M $104.6M
YoY Change -34.01% 57.25%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income -$6.517M $9.768M
YoY Change -166.72% -132.84%
Depreciation, Depletion And Amortization $80.00K $30.00K
YoY Change 166.67% 50.0%
Cash From Operating Activities -$6.470M -$8.270M
YoY Change -21.77% 57.52%
INVESTING ACTIVITIES
Capital Expenditures -$40.00K -$150.0K
YoY Change -73.33% 650.0%
Acquisitions
YoY Change
Other Investing Activities $6.080M -$40.31M
YoY Change -115.08%
Cash From Investing Activities $6.040M -$40.47M
YoY Change -114.92% 202250.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -60.00K 20.00K
YoY Change -400.0% -99.97%
NET CHANGE
Cash From Operating Activities -6.470M -8.270M
Cash From Investing Activities 6.040M -40.47M
Cash From Financing Activities -60.00K 20.00K
Net Change In Cash -490.0K -48.72M
YoY Change -98.99% -190.29%
FREE CASH FLOW
Cash From Operating Activities -$6.470M -$8.270M
Capital Expenditures -$40.00K -$150.0K
Free Cash Flow -$6.430M -$8.120M
YoY Change -20.81% 55.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-20763000
CY2017Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
8311000
CY2016Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
6043000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
3693000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-31041000
CY2017Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
11834000
CY2016Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
27479000
CY2016Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4618000
CY2015Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
37839000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4740000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3574000
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4287000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6840000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8023000
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6521000
CY2017Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
CY2016Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2318000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-693000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
101000
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9764000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22847000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6842000
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4000
CY2016Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
144000
us-gaap Interest And Other Income
InterestAndOtherIncome
114000
us-gaap Interest And Other Income
InterestAndOtherIncome
246000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
32000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
151000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1932000
CY2016Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
838000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1037000
CY2017Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
13000
us-gaap Interest Paid
InterestPaid
2857000
us-gaap Interest Paid
InterestPaid
182000
CY2017Q2 us-gaap Liabilities
Liabilities
108325000
CY2016Q4 us-gaap Liabilities
Liabilities
103583000
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
69048000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
84887000
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6592000
CY2017Q2 us-gaap Interest Expense
InterestExpense
1443000
CY2016Q2 us-gaap Interest Expense
InterestExpense
1475000
us-gaap Interest Expense
InterestExpense
2884000
us-gaap Interest Expense
InterestExpense
2625000
CY2016Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
51003000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-123000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
63632000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6642000
CY2017Q2 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
8311000
CY2016Q4 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
4618000
CY2017Q2 us-gaap Long Term Investments
LongTermInvestments
11215000
CY2016Q4 us-gaap Long Term Investments
LongTermInvestments
8200000
CY2017Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2016Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0
CY2017Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
41107000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
23087000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
11741000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-55201000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-15994000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-12139000
us-gaap Net Income Loss
NetIncomeLoss
-22839000
us-gaap Net Income Loss
NetIncomeLoss
6834000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
9768000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-6517000
CY2016Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
8631000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6036000
CY2016Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-9001000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-21167000
CY2017Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1703000
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
19039000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7243000
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
9275000
us-gaap Operating Expenses
OperatingExpenses
15604000
us-gaap Operating Expenses
OperatingExpenses
16245000
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8224000
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
8224000
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
321000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-9275000
us-gaap Operating Income Loss
OperatingIncomeLoss
-15604000
us-gaap Operating Income Loss
OperatingIncomeLoss
-16245000
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
41000
CY2017Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1472000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1153000
CY2016Q2 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
1137000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
360000
CY2017Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
112000
CY2016Q2 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
18769000
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
28001000
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
673000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
50000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
20922000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
65627000
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
798000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
143000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
219000
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
9250
CY2016Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
14933
CY2017Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
9250
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
14933
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
-39277000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-18696000
us-gaap Share Based Compensation
ShareBasedCompensation
2279000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
13333
kmph Common Stock Issued During Period From Warrants Exercised
CommonStockIssuedDuringPeriodFromWarrantsExercised
698
kmph Common Stock Issued During Period From Warrants Exercised
CommonStockIssuedDuringPeriodFromWarrantsExercised
141095
kmph Deferred Offering Costs Included In Accounts Payable And Accrued Expense
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpense
60000
kmph Deferred Offering Costs Included In Accounts Payable And Accrued Expense
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpense
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2017Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
771000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
489000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Reclassifications</div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">During the&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">second</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;the Company early&nbsp;adopted Accounting Standards Update (&#x201c;ASU&#x201d;) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,</div> </div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;">Statements of Cash Flows (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">320</div>) &#x2013; Restricted Cash</div> (&quot;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18&quot;</div>), which </div>addresses the treatment of restricted cash and restricted cash equivalents in the statement of cash flows<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">. The adoption of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18</div> reduced the Company&#x2019;s net cash used in investing activities and net decrease in cash and cash equivalents on the&nbsp;condensed statements of&nbsp;cash flows&nbsp;by <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.1</div></div> million for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2016, </div>as compared to the net cash used in investing activities and net decrease in cash and cash equivalents on the condensed statements of cash flows if the Company had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> early adopted ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18.</div> This reclassification had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> effect on the condensed balance sheets&nbsp;or statements of operations. </div></div></div></div>
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
82800000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
32806000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
10645000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
4000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
141000
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2148000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1970000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
77000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
15000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
18621000
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4650000
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4988000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8764000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8222000
CY2017Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1100000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1100000
CY2016 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
3
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-144179000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-121340000
CY2017Q2 us-gaap Sales Revenue Net
SalesRevenueNet
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
us-gaap Sales Revenue Net
SalesRevenueNet
us-gaap Sales Revenue Net
SalesRevenueNet
us-gaap Share Based Compensation
ShareBasedCompensation
2254000
CY2016Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
8631000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
6036000
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">The preparation of financial statements in conformity with GAAP<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;requires the Company to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">On an ongoing basis, the Company evaluates its estimates, including those rel<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">ated to the useful lives of property and equipment, and assumptions used for purposes of determining stock-based compensation, income taxes, and the fair value of the derivative and warrant liability, among others. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable, the results of which form the basis for making judgments about the carrying value of assets and liabilities.</div></div></div></div></div>
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15435322
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15583390
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14649586
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14648291
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14597449
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14546576
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14649586
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14648291
kmph Deferred Offering Costs Writeoff
DeferredOfferingCostsWriteoff
kmph Deferred Offering Costs Writeoff
DeferredOfferingCostsWriteoff
445000
CY2017Q2 kmph Derivative And Warrant Liability Noncurrent
DerivativeAndWarrantLiabilityNoncurrent
8311000
CY2016Q4 kmph Derivative And Warrant Liability Noncurrent
DerivativeAndWarrantLiabilityNoncurrent
4618000
CY2017Q2 kmph Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Exercises
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExercises
CY2016Q2 kmph Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Exercises
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExercises
673000
kmph Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Exercises
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExercises
kmph Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Exercises
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityExercises
755000
kmph Fixed Assets Included In Accounts Payable And Accrued Expenses
FixedAssetsIncludedInAccountsPayableAndAccruedExpenses
7000
kmph Fixed Assets Included In Accounts Payable And Accrued Expenses
FixedAssetsIncludedInAccountsPayableAndAccruedExpenses
50000
kmph Transfer Of Warrants To Equity Upon Exercise
TransferOfWarrantsToEquityUponExercise
755000
CY2017Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6303000
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6444000
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5003000
CY2017Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
104901000
kmph Gain Loss On Subleases
GainLossOnSubleases
-102000
kmph Gain Loss On Subleases
GainLossOnSubleases
kmph Transfer Of Warrants To Equity Upon Exercise
TransferOfWarrantsToEquityUponExercise
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
102643000
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1165000
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1257000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2254000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2279000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2220000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2443000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
780000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
835000
CY2017Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
390000
CY2016Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
393000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11692975
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9532398
CY2017Q2 us-gaap Assets
Assets
69048000
CY2016Q4 us-gaap Assets
Assets
84887000
CY2017Q2 us-gaap Assets Current
AssetsCurrent
55364000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
74357000
CY2017Q2 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
52322000
CY2016Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
59203000
CY2017Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
177000
CY2016Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
157000
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
284000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3708000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17862000
CY2015Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32318000
CY2017Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13486000
CY2016Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28610000
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
548000
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12386000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16762000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-4376000
CY2017Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
12621775
CY2016Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
12114618
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14657430
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14646982
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
1000
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14657430
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14646982
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2017Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
91950000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
55000
CY2016Q2 us-gaap Dividends
Dividends
us-gaap Dividends
Dividends
CY2016Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
91170000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
164000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-31041000
CY2017Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3523000
CY2016Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-20763000
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.41
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.56
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.58
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.36
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.56
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
3693000
CY2017Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-3523000

Files In Submission

Name View Source Status
0001437749-17-014436-index-headers.html Edgar Link pending
0001437749-17-014436-index.html Edgar Link pending
0001437749-17-014436.txt Edgar Link pending
0001437749-17-014436-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kmph-20170630.xml Edgar Link completed
kmph-20170630.xsd Edgar Link pending
kmph-20170630_cal.xml Edgar Link unprocessable
kmph-20170630_def.xml Edgar Link unprocessable
kmph-20170630_lab.xml Edgar Link unprocessable
kmph-20170630_pre.xml Edgar Link unprocessable
kmph20170630_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending